NYSEAMERICAN:ELMD Electromed - ELMD Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Electromed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $10.79 -0.26 (-2.35%) (As of 01/31/2023 12:00 AM ET) Add Compare Share Share Today's Range$10.79▼$11.2550-Day Range N/A52-Week Range$8.75▼$13.25Volume14,834 shsAverage Volume6,687 shsMarket Capitalization$91.55 millionP/E Ratio49.05Dividend YieldN/APrice Target$16.75 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Electromed MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside55.2% Upside$16.75 Price TargetShort InterestHealthy0.65% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.00 out of 5 stars 3.5 Analyst's Opinion Consensus RatingElectromed has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $16.75, Electromed has a forecasted upside of 55.2% from its current price of $10.79.Amount of Analyst CoverageElectromed has only been the subject of 1 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.65% of the float of Electromed has been sold short.Short Interest Ratio / Days to CoverElectromed has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Electromed has recently increased by 8.56%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldElectromed does not currently pay a dividend.Dividend GrowthElectromed does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ELMD. Previous Next 1.2 News and Social Media Coverage News SentimentElectromed has a news sentiment score of 0.17. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.72 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Electromed this week, compared to 1 article on an average week. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Electromed insiders have not sold or bought any company stock.Percentage Held by Insiders12.30% of the stock of Electromed is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 31.95% of the stock of Electromed is held by institutions. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Electromed is 49.05, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 145.20.Price to Earnings Ratio vs. SectorThe P/E ratio of Electromed is 49.05, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 157.68.Price to Book Value per Share RatioElectromed has a P/B Ratio of 2.70. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Electromed (NYSEAMERICAN:ELMD) StockElectromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. The firm's products include SmartVest SQL System and SmartVest Connect. It focuses on building market awareness, and acceptance of its products and services with physicians, clinicians, patients, and third-party payers. The company was founded by Robert D. Hansen and Craig N. Hansen in 1992 and is headquartered in New Prague, MN.Read More Receive ELMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Electromed and its competitors with MarketBeat's FREE daily newsletter. Email Address ELMD Stock News HeadlinesOctober 20, 2022 | globenewswire.comMedical Practice Management Software Market Is Expected to Grasp the Value of 13.85 Billion by 2029, Size, Shares, Demand, Rising Trends and Revenue Analysis - GlobeNewswireOctober 20, 2022 | globenewswire.comMedical Practice Management Software Market Is Expected to Grasp the Value of 13.85 Billion by 2029, Size, Shares, Demand, Rising Trends and Revenue Analysis - GlobeNewswireJanuary 31, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.September 20, 2022 | benzinga.comPFPI: Tide Turning on Use of Wood-Burning for Renewable Energy in Europe - BenzingaSeptember 19, 2022 | benzinga.comFrank Stella Enters The Metaverse - BenzingaSeptember 18, 2022 | benzinga.comMark Cuban Thinks Elon Musk's Question About Inflation Is 'Ridiculous', Has This To Say Instead - BenzingaSeptember 16, 2022 | benzinga.comThis Company's Medical Device Could Be A Game Changer For The Military - electroCore (NASDAQ:ECOR), BioSig Technologies (NASDAQ:BSGM) - BenzingaSeptember 15, 2022 | businesswire.comGlobal Airway Management Pipeline Report 2022: Stages of Development, Regulatory Path, Estimated Approval Date, Ongoing Clinical Trials and Key Companies - ResearchAndMarkets.com - Business WireJanuary 31, 2023 | Porter & Company (Ad)The Next Big Crisis Is HereYou just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.September 13, 2022 | benzinga.comElectromed (AMEX:ELMD) – Electromed Earnings Perspective: Return On Capital Employed - BenzingaSeptember 13, 2022 | msn.comElectromed Earnings Perspective: Return On Capital EmployedSeptember 8, 2022 | seekingalpha.comElectromed, Inc.: 2 Potential Paths To A Very Attractive ReturnSeptember 5, 2022 | seekingalpha.comSummers Value Partners Q2 2022 Investor Letter - Seeking AlphaAugust 29, 2022 | globenewswire.comGlobal Neuromodulation Devices Market Anticipated to Grow at a CAGR of 19.7% by 2026, Despite COVID-19 Pandemic Crisis | Report by Research Dive - GlobeNewswireAugust 26, 2022 | stocknews.comEAR: Should You Buy Eargo After the FDA Ruling on Hearing Aids? - StockNews.comAugust 26, 2022 | finance.yahoo.comNortech Systems Announces Patent for Flexible Faraday Cage Printed Circuit Board and Cable - Yahoo FinanceAugust 25, 2022 | businesswire.comNortech Systems Announces Patent for Flexible Faraday Cage Printed Circuit Board and Cable - Business WireAugust 24, 2022 | investing.comElectromed Misses Q2 EPS by 2c By Investing.com - Investing.comAugust 23, 2022 | finance.yahoo.comElectromed, Inc. Announces Fiscal 2022 Fourth Quarter and Full Year Financial ResultsAugust 23, 2022 | au.investing.comElectromed Misses Q2 EPS by 2c By Investing.com - Investing.com AustraliaAugust 23, 2022 | businesswire.comElectromed, Inc. Announces Fiscal 2022 Fourth Quarter and Full Year Financial Results - Business WireAugust 10, 2022 | businesswire.comNortech Systems Announces 2022 Second Quarter Results - Business WireAugust 8, 2022 | finance.yahoo.comThe Global Mucus Clearance Devices Market is expected to grow by $ 193.28 mn during 2022-2026, accelerating at a CAGR of 6.22% during the forecast period - Yahoo FinanceAugust 3, 2022 | finance.yahoo.comBizVibe Adds New Company Insights for 10,000+ Navigational, Measuring, Electromedical, and Control Instrument Companies | Risk Evaluation | Regional Analysis | Similar Companies | Financials and Management Team - Yahoo FinanceAugust 2, 2022 | businesswire.comElectromed, Inc. Schedules its Fourth Quarter and Fiscal 2022 Financial Results Conference Call for August 23, 2022 at 5:00 p.m. ET - Business WireJuly 25, 2022 | businesswire.comElectromed, Inc. Announces Election of Andrew Summers as Additional Independent Director - Business WireJuly 25, 2022 | finance.yahoo.comElectromed, Inc. Announces Election of Andrew Summers as Additional Independent DirectorSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive ELMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Electromed and its competitors with MarketBeat's FREE daily newsletter. Email Address ELMD Company Calendar Last Earnings11/08/2022Today1/31/2023Next Earnings (Estimated)2/06/2023Fiscal Year End6/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNYSEAMERICAN:ELMD Previous SymbolNYSEMKT:ELMD CUSIPN/A CIK1488917 Websmartvest.com Phone(952) 758-9299Fax866-758-5077Employees132Year FoundedN/APrice Target and Rating Average Stock Price Forecast$16.75 High Stock Price Forecast$20.00 Low Stock Price Forecast$13.50 Forecasted Upside/Downside+55.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)$0.22 Trailing P/E Ratio49.05 Forward P/E RatioN/A P/E GrowthN/ANet Income$2.31 million Net Margins4.60% Pretax Margin5.90% Return on Equity5.73% Return on Assets4.90% Debt Debt-to-Equity RatioN/A Current Ratio5.58 Quick Ratio4.96 Sales & Book Value Annual Sales$41.66 million Price / Sales2.20 Cash Flow$0.36 per share Price / Cash Flow29.82 Book Value$4.00 per share Price / Book2.70Miscellaneous Outstanding Shares8,485,000Free Float7,441,000Market Cap$91.55 million OptionableNot Optionable Beta0.48 Key ExecutivesKathleen S. SkarvanPresident, Chief Executive Officer & DirectorBradley M. NagelChief Financial Officer, Secretary & TreasurerChristopher HollandChief Commercial OfficerKristine OwataVice President-Reimbursement & Payer RelationsDiane M. KaufmanVice President-Human ResourcesKey CompetitorsFONARNASDAQ:FONRHyperfineNASDAQ:HYPRMovanoNASDAQ:MOVEBioSig TechnologiesNASDAQ:BSGMVasoOTCMKTS:VASOView All CompetitorsInsiders & InstitutionsAnnex Advisory Services LLCBought 8,568 shares on 1/30/2023Ownership: 0.368%Affiance Financial LLCBought 2,758 shares on 1/20/2023Ownership: 0.033%Vanguard Group Inc.Sold 7,616 shares on 11/15/2022Ownership: 3.546%Royal Bank of CanadaBought 1,030 shares on 11/14/2022Ownership: 1.185%Standard Family Office LLCBought 2,600 shares on 11/14/2022Ownership: 0.031%View All Institutional Transactions ELMD Stock - Frequently Asked Questions Should I buy or sell Electromed stock right now? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Electromed in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ELMD shares. View ELMD analyst ratings or view top-rated stocks. What is Electromed's stock price forecast for 2023? 4 Wall Street research analysts have issued 1-year price targets for Electromed's stock. Their ELMD share price forecasts range from $13.50 to $20.00. On average, they predict the company's stock price to reach $16.75 in the next twelve months. This suggests a possible upside of 48.9% from the stock's current price. View analysts price targets for ELMD or view top-rated stocks among Wall Street analysts. Are investors shorting Electromed? Electromed saw a increase in short interest in January. As of January 15th, there was short interest totaling 43,100 shares, an increase of 8.6% from the December 31st total of 39,700 shares. Based on an average daily volume of 13,600 shares, the days-to-cover ratio is presently 3.2 days. Currently, 0.7% of the company's shares are sold short. View Electromed's Short Interest. When is Electromed's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, February 6th 2023. View our ELMD earnings forecast. How were Electromed's earnings last quarter? Electromed, Inc. (NYSEAMERICAN:ELMD) posted its quarterly earnings results on Tuesday, November, 8th. The medical equipment provider reported $0.01 earnings per share for the quarter. The medical equipment provider earned $10.66 million during the quarter. Electromed had a net margin of 4.60% and a trailing twelve-month return on equity of 5.73%. What other stocks do shareholders of Electromed own? Based on aggregate information from My MarketBeat watchlists, some companies that other Electromed investors own include AbbVie (ABBV), TransEnterix (TRXC), AT&T (T), ACADIA Pharmaceuticals (ACAD), CRISPR Therapeutics (CRSP), Enphase Energy (ENPH), Inseego (INSG), Novavax (NVAX), NVIDIA (NVDA) and Pfizer (PFE). What is Electromed's stock symbol? Electromed trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ELMD." Who are Electromed's major shareholders? Electromed's stock is owned by a number of institutional and retail investors. Top institutional investors include Annex Advisory Services LLC (0.37%), Affiance Financial LLC (0.03%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include A Jones Lee, George H Winn, Michael Joseph Maccourt and Stephen H Craney. View institutional ownership trends. How do I buy shares of Electromed? Shares of ELMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Electromed's stock price today? One share of ELMD stock can currently be purchased for approximately $11.25. How much money does Electromed make? Electromed (NYSEAMERICAN:ELMD) has a market capitalization of $95.46 million and generates $41.66 million in revenue each year. The medical equipment provider earns $2.31 million in net income (profit) each year or $0.22 on an earnings per share basis. How many employees does Electromed have? The company employs 132 workers across the globe. How can I contact Electromed? Electromed's mailing address is 500 6th Ave NW, NEW PRAGUE, MN 56071-1134, United States. The official website for the company is smartvest.com. The medical equipment provider can be reached via phone at (952) 758-9299, via email at investorrelations@electromed.com, or via fax at 866-758-5077. This page (NYSEAMERICAN:ELMD) was last updated on 1/31/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.